Michael Postow, MD, Memorial Sloan Kettering Cancer Center, New York, NY, outlines areas of unmet needs in melanoma. These include treatment approaches for BRAF wild-type patients who have progressed on prior immune checkpoint blockade, as well as NRAS mutant melanoma patients. Unmet needs also discussed by Dr Postow include improvements in outcomes of patients with brain metastases. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

свернуть